ProPhase Labs, Inc. (PRPH)

$ 7.01
-0.06 (-0.83%)
Symbol PRPH
Price $ 7.01
Beta -0.186
Volume Avg. 0.35M
Market Cap 0.11B
Shares () -
52 Week Range 1.75-16.04
1y Target Est -
DCF Unlevered -
DCF Levered -
ROE 3.38% Neutral
ROA 0.84% Neutral
Operating Margin -
Debt / Equity 62.24% Buy
P/E -
P/B 1.98 Strong Buy


Consensus EPS

Upgrades & Downgrades


Mr. Ted Karkus
Drug Manufacturers—Specialty & Generic
Nasdaq Capital Market

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. The company is headquartered in Doylestown, Pennsylvania and currently employs 54 full-time employees. The firm is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The firm's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The firm's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.